Title Image

R&D

HND-027
HND-027-
Indication Oncology
Status – CDMO Tech-transfer ongoing.

– ODD granted on December 23th, 2020.

Product Advantages Handa is utilizing its ONCORE™ technology to develop improved versions of Oncology drug for reducing the risk associated with sever side effect and improve bioavailability.
Potential Market Oncology market value is $133 billion in 2017.

judi online infini88 slot pg slot baccarat online slot idn live idn poker judi bola tangkasnet pragmatic slot88 sbobet slot deposit dana casino online vegas slot pokerseri joker123 autowin88 warungtoto selot